Kioi M - Search Results

1

NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.

Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, Xi Y, Park BH, Shi X, Garcia BA, Li W, Gozani O. Kuo AJ, et al. Among authors: kioi m. Mol Cell. 2011 Nov 18;44(4):609-20. doi: 10.1016/j.molcel.2011.08.042. Mol Cell. 2011. PMID: 22099308 Free PMC article.

2

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.

Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen K, Struhl K, Garcia BA, Gozani O, Li W, Chua KF. Barber MF, et al. Among authors: kioi m. Nature. 2012 Jul 5;487(7405):114-8. doi: 10.1038/nature11043. Nature. 2012. PMID: 22722849 Free PMC article.

3

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.

Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, Chua KF. Michishita E, et al. Among authors: kioi m. Nature. 2008 Mar 27;452(7186):492-6. doi: 10.1038/nature06736. Epub 2008 Mar 12. Nature. 2008. PMID: 18337721 Free PMC article.

4

Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

Liu SC, Ahn GO, Kioi M, Dorie MJ, Patterson AV, Brown JM. Liu SC, et al. Among authors: kioi m. Cancer Res. 2008 Oct 1;68(19):7995-8003. doi: 10.1158/0008-5472.CAN-08-1698. Cancer Res. 2008. PMID: 18829557 Free PMC article.

5

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.

Walters MJ, Ebsworth K, Berahovich RD, Penfold ME, Liu SC, Al Omran R, Kioi M, Chernikova SB, Tseng D, Mulkearns-Hubert EE, Sinyuk M, Ransohoff RM, Lathia JD, Karamchandani J, Kohrt HE, Zhang P, Powers JP, Jaen JC, Schall TJ, Merchant M, Recht L, Brown JM. Walters MJ, et al. Among authors: kioi m. Br J Cancer. 2014 Mar 4;110(5):1179-88. doi: 10.1038/bjc.2013.830. Epub 2014 Jan 14. Br J Cancer. 2014. PMID: 24423923 Free PMC article.

6

Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma.

Shimamura T, Royal RE, Kioi M, Nakajima A, Husain SR, Puri RK. Shimamura T, et al. Among authors: kioi m. Cancer Res. 2007 Oct 15;67(20):9903-12. doi: 10.1158/0008-5472.CAN-06-4558. Cancer Res. 2007. PMID: 17942922

7

Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.

Kioi M, Takahashi S, Kawakami M, Kawakami K, Kreitman RJ, Puri RK. Kioi M, et al. Cancer Res. 2005 Sep 15;65(18):8388-96. doi: 10.1158/0008-5472.CAN-05-1043. Cancer Res. 2005. PMID: 16166317

8

Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.

Kioi M, Kawakami K, Puri RK. Kioi M, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6231-8. doi: 10.1158/1078-0432.CCR-04-0700. Clin Cancer Res. 2004. PMID: 15448012

9

Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK. Kioi M, et al. Cancer. 2006 Sep 15;107(6):1407-18. doi: 10.1002/cncr.22134. Cancer. 2006. PMID: 16902988 Free article.

10

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Kioi M, et al. J Clin Invest. 2010 Mar;120(3):694-705. doi: 10.1172/JCI40283. Epub 2010 Feb 22. J Clin Invest. 2010. PMID: 20179352 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page